GRIFOLS ANTITHROMBIN SCIENTIFIC AWARDS
Introduction: The GATRA is a program whose aim is to identify and support innovative clinical and scientific research aimed at gaining more insight into the current and new uses of Antithrombin, thus the GRIFOLS ANTITHROMBIN SCIENTIFIC AWARDS.
By supporting this program Grifols demonstrates its commitment to innovation in this field. We consider the program to be a tangible contribution to the improvement of standards and benefits for the patient care.
GATRA aims to:
By supporting this program Grifols demonstrates its commitment to innovation in this field. We consider the program to be a tangible contribution to the improvement of standards and benefits for the patient care.
GATRA aims to:
- Develop novel concepts on Antithrombin research.
- Encourage discovery of beneficial Antithrombin applications.
- Further investigate mechanisms of action or clinical effects in different indications.
- Establish new and long-lasting cooperation with participating scientists and clinicians.
- Strengthen and increase the existing network between researchers and the company.
- Foster relationships with KOLs in different fields.
Value
These unique opportunities may include, but are not limited to:
The Program offers 2 awards of EUR 50,000
Eligibility
Eligibility requirements are as follows:
- Scientists or clinicians with an innovative idea relevant to Antithrombin research. Applications are encouraged from both individuals and teams who may be undertaking research at universities, hospitals or independent research institutions.
- The work submitted must represent an original contribution to basic or clinical research and be specifically related to Antithrombin.
- Applicants must present a focused project with goals that can be achieved within 12 months.
- Participants must fulfill a Letter of Intent (LOI), providing:
- Basic details of professional position
- Short CV in PDF
- Summary protocol
- Applicants must be employed or supported by a university, hospital or independent research institution.
- Scientific merit
- Innovation of project
- Clinical and medical impact
- Research environment/qualification of the applicant
Deadline: July .
Best of Luck!
No comments:
Post a Comment